Entering text into the input field will update the search result below

Abbott wins FDA expanded indication for Eterna neuromodulation device

May 11, 2023 10:16 AM ETAbbott Laboratories (ABT)BSX, MDT, NVROBy: Dulan Lokuwithana, SA News Editor
Abbott Vascular headquarters in Silicon Valley

Sundry Photography/iStock Editorial via Getty Images

Abbott Laboratories (NYSE:ABT) announced Thursday that the FDA approved expanded MRI labeling for its pain relief device Eterna spinal cord stimulation (SCS) system, allowing its use in patients who require MRI scanning.

Citing a recent study, the company noted that 93% of

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.